Position in CDXS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,006,263
+$1,232,779 QoQ
Shares Held
1,330,205
+22.3% QoQ
Ownership
1.21%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 148 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $740,535,030 across 80 Biotechnology names. CDXS ranks #36 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,503 | $159,939,880 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
2,939,719 | $98,157,217 | |
| 3 | INCY |
Incyte Corp
|
731,774 | $82,953,900 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
695,532 | $60,476,507 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
322,377 | $25,232,447 | |
| 6 | EXEL |
Exelixis, Inc.
|
415,650 | $22,615,516 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,231,516 | $20,898,826 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
60,986 | $18,358,615 |
All Filings in CDXS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,006,263 | 1,330,205 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,773,484 | 1,088,027 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,850,359 | 1,135,190 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,842,224 | 1,164,846 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $2,874,639 | 1,178,131 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,878,980 | 1,070,253 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,106,755 | 860,955 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,758,740 | 895,695 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,130,655 | 1,009,889 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,652,899 | 1,046,676 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,172,363 | 1,367,988 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,084,222 | 1,631,864 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $3,591,263 | 1,282,594 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,436,337 | 1,313,125 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,070,083 | 1,302,593 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,045,668 | 1,327,668 | Shares | Sole | 2022-11-15 | |
| No filing history on record for this holder in this stock. | ||||||